Digital therapeutics — software-based interventions that treat, manage, or prevent medical conditions — have reached a pivotal moment. A growing number of DTx products hold FDA clearance and are seeking insurance reimbursement as a pathway to scale beyond direct-to-consumer models. That ambition comes with a formidable administrative overhead: payer contracting, prior authorization management, and patient onboarding all require sustained operational capacity that early-stage DTx companies often lack. In 2026, virtual assistants are becoming a practical solution to this challenge.
The Reimbursement Pathway and Its Administrative Demands
Prescription digital therapeutics face a reimbursement landscape that has no established playbook. Unlike pharmaceutical products that follow well-worn coverage review processes, DTx products must educate payer medical directors, negotiate coverage policies, navigate medical necessity criteria, and build billing infrastructure from scratch in each new payer relationship.
A 2024 IQVIA analysis of DTx market access found that the average time from payer engagement to active coverage policy was 18 to 24 months, with administrative process management identified as a key bottleneck alongside clinical evidence requirements. Companies with structured administrative support for payer follow-up and documentation moved through the contracting process measurably faster than those relying solely on market access executives.
Once a payer contract is in place, ongoing administration begins: submitting prior authorization requests for newly prescribed patients, managing authorization renewals, tracking claim submissions and remittance, and coordinating billing inquiries from prescribing physicians. This operational layer grows with every payer added and every new patient prescribed.
Prior Authorization and Patient Access
Prior authorization is one of the most significant friction points in DTx patient access. Even when a payer has an active coverage policy, individual patient prescriptions frequently require authorization — and the authorization process requires documentation, follow-up, and appeals when denials occur.
Virtual assistants manage prior authorization workflows with consistency and volume capacity that internal staff cannot always match. A VA can submit authorization requests through payer portals, track pending cases, draft appeal letters for denied authorizations, and maintain a status log that keeps prescribers informed about their patients' access timelines. This systematic execution converts a chaotic follow-up burden into a managed workflow.
For DTx companies serving patients with chronic conditions — where access delays directly affect treatment adherence and clinical outcomes — faster prior authorization resolution is not just an operational metric. It is a care quality issue. McKinsey's 2025 digital health access report noted that patients who experience delays of more than two weeks between prescription and access have materially lower treatment initiation rates.
Payer Contracting Administration
Negotiating a payer contract is a strategic and clinical function. Managing the administrative work around contracting — tracking open requests, coordinating document submissions, following up on outstanding terms, and maintaining contract records — is an operational function. Virtual assistants take on the operational layer, keeping contracting pipelines moving while market access executives focus on relationship strategy and evidence communication.
VAs also support the ongoing maintenance of payer relationships: distributing utilization reports, coordinating quarterly business reviews, managing contract renewal calendars, and handling the correspondence flow that keeps active payer relationships in good standing.
Patient Onboarding and Prescription Fulfillment Coordination
When a physician prescribes a digital therapeutic, the patient must be activated on the platform — which typically involves identity verification, device or app setup, benefit verification, and orientation to the treatment program. These steps are administratively intensive and must be completed promptly to avoid treatment abandonment.
Virtual assistants coordinate the patient onboarding process: confirming insurance coverage, sending app access instructions, following up with patients who have not completed activation, and escalating clinical or technical issues to the appropriate team. This onboarding support directly affects the patient activation rates that DTx companies track as a primary commercial metric.
DTx operators seeking to reduce administrative drag in their payer relations and patient access functions can explore virtual assistant support through Stealth Agents, which provides trained assistants for healthcare market access operations.
Building Administrative Infrastructure for Scale
DTx companies preparing for commercial scale need administrative infrastructure that can grow with their patient volumes and payer footprint. Virtual assistants provide a flexible capacity model — scalable as patient volumes grow, adjustable as payer mix evolves, and cost-efficient compared to expanding internal headcount for roles that are fundamentally operational rather than strategic.
Sources
- IQVIA, "Digital Therapeutics: Market Access and Reimbursement Landscape," 2024
- McKinsey & Company, "Digital Health Access: Reducing Barriers to Prescription Therapy," 2025
- Digital Therapeutics Alliance, "Payer Coverage and Reimbursement Framework for DTx," 2024